Enzyme-Linked Immunosorbent Spot (ELISpot) and FluoroSpot build on familiar immunoassay principles to assess the frequency of antigen-specific cytokine-secreting cells at a single cell level. With its high sensitivity, it can detect low antigen-specific responses and be used to complement information from other functional assays, including intra-cellular cytokine staining (ICS) by flow cytometry and ELISA.
ELISpot and FluoroSpot assays are used to characterize pre-existing immune responses, monitor the immunogenicity of vaccines, and assess the effects of immune-modulating therapies in fields such as cancer, infectious diseases, autoimmune and rare/orphan diseases.
Our scientists have extensive experience in customizing and validating ELISpot assays to specific antigens for exploratory, secondary, or primary endpoint use in clinical trials.
ELISpot is an efficient assay which requires the use of a small number of cells, allowing for multiple stimulations, and necessitates minimal cell manipulations (no fixation / permeabilization). It is also a highly sensitive method, usually showing sensitivity higher than an intra-cellular cytokine staining.
Caprion also has expertise with the cultured ELISpot assay which allows the monitoring of responses by memory T cells.
Fit-for-purpose ELISpot assay for the detection of IFNγ
With FluoroSpot assays, analyte secreting cells are detected using antibodies labeled with fluorophores instead of enzymes, resulting in a one-step direct detection as compared to the two-step detection system of ELISpot.
FluoroSpot also has the advantage to enable the analysis of multiple analytes in one well. The technology allows for the identification of cells producing each analytes as well as the ones producing both of these analytes.
Our experienced team can customize both ELISpot and FluoroSpot assays according to the antigen stimulation selected and the cell type investigated. The well-established validation process we follow leads to optimized assays and guarantee confidence in your results.